Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Artificial Intelligence In Life Sciences Market Forecast Highlighting Growth From $4.44 Billion To $10.42 Billion

In the realm of life sciences, the artificial intelligence market has experienced remarkable expansion, projected to ascend from $3.59 billion in 2025 to $4.44 billion by 2026, a trajectory defined by a compound annual growth rate of 23.6%. This significant upswing during the past period is underpinned by several pivotal factors, including the escalating intricacy of biological data, a broader engagement in genomics research, the increasing embrace of digital laboratory tools, the early incorporation of AI within biotechnology endeavors, and the persistent need for accelerated research timelines.

Anticipate a period of substantial expansion for the artificial intelligence within the life sciences sector, with projections indicating it will reach a valuation of $10.43 billion by 2030. This impressive trajectory is fueled by a compound annual growth rate of 23.8%, driven by escalating investments in personalized medicine, the broader implementation of AI-powered laboratory automation, the proliferation of cloud solutions for life science applications, amplified partnerships between technology and life science organizations, and increasing regulatory endorsement of AI-derived findings. Key developments shaping this market during the projected timeframe encompass the deeper embedding of AI throughout life science processes, a surge in the utilization of AI-driven data analysis tools, greater reliance on automation in laboratory settings, the expanding application of AI in precision medicine, and a heightened emphasis on expediting research results.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13587&type=smp

#Artificial Intelligence In Life Sciences Market Growth Drivers And Industry Catalysts

The expanding adoption of real-time remote patient monitoring (RPM) systems is poised to fuel advancements within the artificial intelligence in the life sciences market. These RPM systems represent a technologically advanced approach to healthcare, enabling health observation beyond conventional clinical environments. Artificial intelligence plays a crucial role in enhancing RPM by delivering ongoing, tailored, and data-informed perspectives that facilitate proactive health management. Illustrating this trend, data from the Peterson Center on Healthcare revealed a substantial increase in spending for remote therapeutic monitoring (RTM) within Traditional Medicare, escalating from $2.2 million in 2022 to $10.4 million in 2023. Moreover, in 2023, the utilization of RPM services was noted among 451,000 patients enrolled in Traditional Medicare, underscoring how the growing demand for contemporary remote patient monitoring solutions is directly stimulating the expansion of artificial intelligence applications in the life sciences sector.

Artificial Intelligence In Life Sciences Market Segment Outlook: Which Categories Are Expanding The Fastest?

The artificial intelligence in life sciences market covered in this report is segmented –

1) By Offering: Software, Hardware, Services

2) By Deployment: On-Premises, Cloud-Based

3) By Application: Drug Discovery, Medical Diagnosis, Biotechnology, Clinical Trials, Precision And Personalized Medicine, Patient Monitoring

Subsegments:

1) By Software: Drug Discovery Software, Genomic Analysis Software, Clinical Trial Management Software, Personalized Medicine Software, Laboratory Information Management Systems (LIMS)

2) By Hardware: AI-Enabled Laboratory Equipment, Robotics And Automation Systems, Imaging Devices And Equipment, Sensor Technologies

3) By Services: Consulting Services, Data Analytics Services, Research And Development Services, Implementation And Integration Services, Training And Support Services

#Artificial Intelligence In Life Sciences Market Trends Influencing Long-Term Demand

Leading corporations in the AI within life sciences sector are prioritizing novel offerings equipped with cutting-edge technology, exemplified by drug discovery software solutions, as a strategy to maintain their market standing. This drug discovery software encompasses a suite of computational tools and platforms engineered to support pharmaceutical and biotech professionals throughout the drug discovery pipeline. As a prime illustration, in December of 2023, the German multinational science and technology firm Merck introduced AIDDISON, a revolutionary drug discovery software. This pioneering system, the first of its kind, integrates the creation of virtual molecules with practical manufacturing considerations by leveraging generative artificial intelligence, machine learning algorithms, and computer-aided drug design principles. AIDDISON excels at pinpointing potential drug candidates from an extensive array of options, taking into account essential attributes such as non-toxicity and solubility. Its capacity to effectively reconcile theoretical molecular design with tangible production realities represents a significant contribution of artificial intelligence to the life sciences field.

Artificial Intelligence In Life Sciences Market Key Companies And Competitive Benchmarking

Major companies operating in the artificial intelligence in life sciences market are Google LLC, Microsoft Corporation, Intel Corporation, IBM Corporation, Medtronic PLC, Nvidia Corporation, Novo Nordisk A/S, Siemens Healthineers AG, Philips Healthcare, Babylon Healthcare Services Ltd., Komodo Health Inc., Modernizing Medicine Inc., Viz.ai Inc., Butterfly Network Inc., Augmedix, AiCure LLC, HealthTap Inc., Welltok Inc., Enlitic Inc., PathAI Inc., Nano-X Imaging Ltd., Berg LLC, Insitro, Sense.ly Inc., Subtle Medical Inc., Medasense Biometrics Limited, Immunai, Atomwise Inc., Freenome Holdings Inc., CloudMedX Inc.

Access The Complete Artificial Intelligence In Life Sciences Market Report:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-life-sciences-global-market-report

Artificial Intelligence In Life Sciences Market Geographic Landscape: Which Region Dominates Industry Growth?

North Americawas the largest region in the Artificial Intelligence In Life Sciences market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in life sciences market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model